Ono Pharmaceutical Co.-Un ADROPHLY
13F holders, Q1 2025 (March 31)6holders +2
3new positions
1sold out
$3.54avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Ono Pharmaceutical Co.-Un ADR (OPHLY) in their 13F filings, up 2 from Q4 2024. 3 opened new positions and 1 sold out. The largest holders were Rhumbline Advisers ($74K), Fulton Bank, N.A. ($41K) and Canopy Partners, LLC ($38K).
- Company
- Ono Pharmaceutical Co.-Un ADR
- CUSIP
- 682736103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $80K |
| Exits | 1 | $47K |
All 13F filers, Q4 2024 → Q1 2025: 22,602 shares bought and 20,805 shares sold, net +1,797 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Rhumbline Advisers | 0.00% | Reduce -2.3% | 21,054 | $74K |
| Fulton Bank, N.A. | 0.00% | New | 11,496 | $41K |
| Canopy Partners, LLC | 0.01% | New | 10,707 | $38K |
| GAMMA Investing LLC | 0.00% | Reduce -53.7% | 5,940 | $21K |
| PNC Financial Services Group, Inc. | 0.00% | New | 399 | $1K |
| First Horizon Advisors, Inc. | 0.00% | No change | 107 | $376 |
"% of holder's portfolio" is OPHLY's weight in each manager's 13F, not the share of Ono Pharmaceutical Co.-Un ADR the manager owns.